Evidence map›Paper›PMID 9465095›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet.

C H Sorli, H J Zhang, M B Armstrong, R V Rajotte, J Maclouf, R P Robertson

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Human Islet Expression Levels of Prostaglandin EACS pharmacology & translational science · 2021
    Article
  6. Article
  7. Article
  8. Prostaglandins in asthma and allergic diseases.Pharmacology & therapeutics · 2019
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

C H SorliDiabetes Center, University of Massachusetts, Worcester, MA 01655, USA.
H J Zhang
M B Armstrong
R V Rajotte
J Maclouf
R P Robertson
Pacific Northwest Diabetes Research Institute · USInserm · FR

Funding

PGE RECEPTOR - LIVER AND FAT METABOLISMR01DK038325 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ROBERTSON, RODERICK PAUL · 1986 to 2010
$3.6M
NIDDK NIH HHS R01 DK038325NIDDK NIH HHS R0I-DK-38325
6 · The paper itself

Abstract

The enzyme cyclooxygenase (COX)-1 is constitutive whereas COX-2 is regulated in virtually all tissues. To assess whether this dogma holds true in the pancreatic islet, we examined basal and interleukin (IL)-1-regulated expression of COX-2 in HIT-T15 cells, Syrian hamster and human islets, and other Syrian hamster tissues. We found that COX-2, and not COX-1, gene expression is dominant in pancreatic islet tissue under both basal and IL-1-stimulated conditions. Control tissues (liver, spleen, and kidney) showed the expected predominance of COX-1 gene expression. Basal and IL-1-stimulated prostaglandin E2 synthesis were blocked by a specific COX-2 inhibitor. IL-1 stimulation had a biphasic effect on COX-2 mRNA levels with an initial mild increase at 2-4 hr followed by a more dramatic decrease below basal level by 24 hr. The IL-1-induced increase in COX-2 mRNA levels was accompanied by a parallel increase in NF-kappaB binding to COX-2 promoter elements. The subsequent decrease in COX-2 mRNA levels was accompanied by a parallel decrease in NF-IL-6 binding activity and COX-2 promoter activity. Specific mutation of the NF-IL-6 binding motif within the COX-2 promoter reduced basal promoter activity by 50% whereas mutation of the NF-kappaB motif had no effect. These studies provide documentation of NF-IL-6 in the pancreatic islet and that COX-2, rather than COX-1, is dominantly expressed. They suggest coordinate regulation by IL-1 of COX-2 mRNA, NF-kappaB, and NF-IL-6 and raise the issue of whether intrinsically high levels of COX-2 gene expression predisposes the normal islet for microenvironmentally induced overproduction of islet prostaglandin E2.

Indexed as

AnimalsCCAAT-Enhancer-Binding ProteinsCells, CulturedCricetinaeCyclooxygenase 1Cyclooxygenase 2DinoprostoneDNA-Binding ProteinsGene Expression Regulation, EnzymologicHumansInterleukin-1Islets of LangerhansIsoenzymesMembrane ProteinsMutagenesisNF-kappa BCCAAT-Enhancer-Binding ProteinsCyclooxygenase 1Cyclooxygenase 2DinoprostoneDNA-Binding ProteinsInterleukin-1IsoenzymesMembrane ProteinsNF-kappa BNuclear ProteinsProstaglandin-Endoperoxide SynthasesPTGS1 protein, humanPTGS2 protein, humanRNA, Messenger

Identifiers

PMID9465095
PMCPMC19191
OpenAlexW1991179596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.